Neurocrine (NBIX) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

Neurocrine Biosciences (NBIX) reported $622.1 million in revenue for the quarter ended September 2024, representing a year-over-year increase of 24.7%. EPS of $1.24 for the same period compares to $0.82 a year ago.The reported revenue compares to the Zacks Consensus Estimate of $604.11 million, representing a surprise of +2.98%. The company delivered an EPS surprise of -15.65%, with the consensus EPS estimate being $1.47.While investors closely watch year-over-year changes in headline numbers -- revenue and ...